| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -8.4e-05 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 9.3e-05 | 1 |